AOD-9604 has some clinical trial data, though it has not achieved widespread regulatory approval for weight loss
DSIP crosses the blood-brain barrier freely an unusual property for a peptide of its size via a non-competitive, non-saturable passive mechanism whose physicochemical determinants (lipophilicity, charge, molecular weight, and protein-binding) are now well characterised
Duration: Expect to supplement for at least 48 weeks before evaluating effects
Regulatory & manufacturing hurdles Finally, translating ferroptosis-targeting strategies into real-world therapies faces practical development challenges
A more recent study has also characterized the impact of Schwann cell-specific MCT1 or MCT4 ablation on nerve biology during development ( FIGURE 1 Lactate transport through MCT1 in the PNS also has an essential role in axonal regeneration following injury, potentially through metabolic support from Schwann cells to axons (Morrison et al., 2015)